Press Releases

Date Title
5/12/20 Sarepta Therapeutics to Present at the 2020 RBC Capital Markets Virtual Global Healthcare Conference
5/11/20 Sarepta Therapeutics and Dyno Therapeutics Announce Agreement to Develop Next-Generation Gene Therapy Vectors for Muscle Diseases
5/6/20 Sarepta Therapeutics Announces First Quarter 2020 Financial Results and Recent Corporate Developments
4/30/20 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/29/20 Sarepta Therapeutics to Announce First Quarter 2020 Financial Results and Recent Corporate Developments on May 6, 2020
4/28/20 Sarepta Therapeutics Announces Research Agreement with U.S. Department of Defense to Evaluate Multiple Constructs From its Proprietary RNA Platform as Treatments for COVID-19
3/31/20 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/19/20 Sarepta’s Response to COVID-19
2/28/20 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/27/20 Sarepta Therapeutics Announces Third Year of Route 79, The Duchenne Scholarship Program
Displaying 81 - 90 of 699